ArticleCancer medicine2023

Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.

Jun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.